Detalles de la búsqueda
1.
Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas.
Eur J Haematol
; 112(2): 276-285, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845834
2.
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR.
Eur J Haematol
; 110(2): 188-197, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335432
3.
Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML.
Eur J Haematol
; 106(5): 606-615, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249666
4.
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2167-2171, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31284069
5.
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(7): 1399-1405, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29684563
6.
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.
Br J Haematol
; 182(3): 418-422, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29808926
7.
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.
Blood
; 127(7): 938-47, 2016 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26670632
8.
Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients.
Haematologica
; 108(10): 2799-2802, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815380
9.
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Biol Blood Marrow Transplant
; 21(12): 2091-2099, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26253007
10.
Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.
Acta Haematol
; 134(3): 146-54, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25968483
11.
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
Biol Blood Marrow Transplant
; 20(3): 382-6, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24321747
12.
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood
; 120(20): 4256-62, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23007405
13.
Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.
Cancers (Basel)
; 16(3)2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339266
14.
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 59(4): 550-557, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321269
15.
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.
Bone Marrow Transplant
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698080
16.
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 19(3): 398-404, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23078786
17.
Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation.
Hemasphere
; 7(7): e921, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37404772
18.
Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis.
Bone Marrow Transplant
; 58(7): 755-761, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37002409
19.
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
Br J Haematol
; 159(2): 172-81, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22909192
20.
Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia.
Transplant Cell Ther
; 28(5): 267.e1-267.e7, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066212